Medicare Enrolled

Dr. Melissa Garth, APRN

Acute Care Nurse Practitioner · Ocala, FL
Low-engagement
1395 SE 63RD COURT RD, Ocala, FL 34472
7205565732
In practice since 2020 (5 years)
NPI: 1225640113 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garth from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garth? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garth

Dr. Melissa Garth is an acute care nurse practitioner in Ocala, FL, with 5 years in practice.

Between the years covered by Open Payments, Dr. Garth received a total of $4,417 from 45 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in acute care nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garth is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice$ $4,417 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,417
Total received (2022-2024)
Avg $1,472/year across 3 years
Top 4% in FL for acute care nurse practitioner
45
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,782 (85.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$635 (14.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,148
2023
$2,031
2022
$237

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$586
Astellas Pharma US Inc
$506
Incyte Corporation
$267
Merck Sharp & Dohme LLC
$252
Takeda Pharmaceuticals U.S.A., Inc.
$239
Eisai Inc.
$237
AstraZeneca Pharmaceuticals LP
$220
Bayer Healthcare Pharmaceuticals Inc.
$205
JAZZ PHARMACEUTICALS INC.
$186
Lilly USA, LLC
$153
Daiichi Sankyo Inc.
$126
Janssen Biotech, Inc.
$119
Celgene Corporation
$101
PFIZER INC.
$89
Gilead Sciences, Inc.
$87
MorphoSys, US Inc.
$83
Regeneron Healthcare Solutions, Inc.
$83
Seagen Inc.
$76
PharmaEssentia USA Corporation
$67
ABBVIE INC.
$57
Mirati Therapeutics, Inc.
$55
Stemline Therapeutics Inc.
$51
Ipsen Biopharmaceuticals, Inc
$43
EMD Serono, Inc.
$41
Pharmacosmos Therapeutics Inc.
$40
AVEO Pharmaceuticals, Inc.
$39
ARRAY BIOPHARMA INC
$38
GENZYME CORPORATION
$37
Genentech USA, Inc.
$35
Heron Therapeutics, Inc.
$27
BeiGene USA, Inc.
$25
ADC Therapeutics America, Inc.
$23
Deciphera Pharmaceuticals Inc.
$22
Tempus AI, Inc
$20
Alexion Pharmaceuticals, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
Rigel Pharmaceuticals, Inc.
$20
G1 Therapeutics, Inc.
$19
Karyopharm Therapeutics Inc.
$17
Taiho Oncology, Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
EISAI INC.
$15
Pharmacyclics LLC, An AbbVie Company
$14
Foundation Medicine, Inc.
$13
Alnylam Pharmaceuticals Inc.
$13
Top 3 companies account for 30.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · ANDEXXA · BESREMI · BOSULIF · BRAFTOVI · CALQUENCE · CINVANTI · COSELA · DARZALEX · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GIVLAARI · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUTATHERA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nubeqa · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Polivy · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · Stivarga · TABRECTA · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tibsovo · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XPOVIO · XT CDX · Xospata · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for acute care nurse practitioner in FL.

Looking for a acute care nurse practitioner in Ocala?
Compare acute care nurse practitioners in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse acute care nurse practitioners nearby

Geographic Context

Acute Care Nurse Practitioners within 10 mi
23
Per 100K population
5.9
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
8.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garth is a acute care nurse practitioner, and high industry engagement (low-engagement, top 4%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Garth receive payments from pharmaceutical companies?
Yes. Dr. Garth received a total of $4,417 from 45 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Garth) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →